Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Poon

Showing results (471-480 of 516) with videos related to

Pageof 52
Sort By:
Vaccine|September 14, 2024
Durability for 12 months of antibody response to a booster dose of monovalent BNT162b2 in adults who had initially received 2 doses of inactivated vaccineEunice Y C Shiu, Samuel M S Cheng, Mario Martín-Sánchez, et al.
Virus Evolution|July 16, 2025
Surveillance of coronaviruses in wild aquatic birds in Hong Kong: expanded genetic diversity and discovery of novel subgenus in the <i>Deltacoronavirus</i>Daisy Y M Ng, Wanying Sun, Thomas H C Sit, et al.
Journal of Virology|September 18, 2015
Evidence for an Ancestral Association of Human Coronavirus 229E with BatsVictor Max Corman, Heather J Baldwin, Adriana Fumie Tateno, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 6, 2023
Serological assays for differentiating natural COVID-19 infection from vaccine induced immunitySamuel M S Cheng, Jonathan J Lau, Leo C H Tsang, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infectionsHuibin Lv, Nicholas C Wu, Owen Tak-Yin Tsang, et al.
Cell Reports|May 20, 2020
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV InfectionsHuibin Lv, Nicholas C Wu, Owen Tak-Yin Tsang, et al.
Nature|July 9, 2004
Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern AsiaK S Li, Y Guan, J Wang, et al.
Nature Medicine|January 20, 2022
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccinationSamuel M S Cheng, Chris Ka Pun Mok, Yonna W Y Leung, et al.
Diabetes Care|April 19, 2023
Differential Associations of GAD Antibodies (GADA) and C-Peptide With Insulin Initiation, Glycemic Responses, and Severe Hypoglycemia in Patients Diagnosed With Type 2 DiabetesBaoqi Fan, Cadmon K P Lim, Emily W M Poon, et al.
Cell Reports|January 27, 2021
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV InfectionsHuibin Lv, Nicholas C Wu, Owen Tak-Yin Tsang, et al.
Pageof 52

Showing results (471-480 of 516) with videos related to

Sort By:
Pageof 52
Vaccine|September 14, 2024
Durability for 12 months of antibody response to a booster dose of monovalent BNT162b2 in adults who had initially received 2 doses of inactivated vaccineEunice Y C Shiu, Samuel M S Cheng, Mario Martín-Sánchez, et al.
Virus Evolution|July 16, 2025
Surveillance of coronaviruses in wild aquatic birds in Hong Kong: expanded genetic diversity and discovery of novel subgenus in the <i>Deltacoronavirus</i>Daisy Y M Ng, Wanying Sun, Thomas H C Sit, et al.
Journal of Virology|September 18, 2015
Evidence for an Ancestral Association of Human Coronavirus 229E with BatsVictor Max Corman, Heather J Baldwin, Adriana Fumie Tateno, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 6, 2023
Serological assays for differentiating natural COVID-19 infection from vaccine induced immunitySamuel M S Cheng, Jonathan J Lau, Leo C H Tsang, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infectionsHuibin Lv, Nicholas C Wu, Owen Tak-Yin Tsang, et al.
Cell Reports|May 20, 2020
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV InfectionsHuibin Lv, Nicholas C Wu, Owen Tak-Yin Tsang, et al.
Nature|July 9, 2004
Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern AsiaK S Li, Y Guan, J Wang, et al.
Nature Medicine|January 20, 2022
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccinationSamuel M S Cheng, Chris Ka Pun Mok, Yonna W Y Leung, et al.
Diabetes Care|April 19, 2023
Differential Associations of GAD Antibodies (GADA) and C-Peptide With Insulin Initiation, Glycemic Responses, and Severe Hypoglycemia in Patients Diagnosed With Type 2 DiabetesBaoqi Fan, Cadmon K P Lim, Emily W M Poon, et al.
Cell Reports|January 27, 2021
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV InfectionsHuibin Lv, Nicholas C Wu, Owen Tak-Yin Tsang, et al.
Pageof 52